Kerala

Technical Eval

Goods

Medicines

Re-Tender for the procurement of anti cancer drugs for the year 2026-27

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 21 Aug 2026Closed

Timeline

Published11 Aug 2026
Closed21 Aug 2026
Technical Evaluation16 Sept 2026
Award—

Bids

4 Bids16 Sept 2026

#	Company	Status
1	Beta Drugs Limited Accepted-Technical NA \| NA \| NA \| 121004	Accepted-Technical Details in notice
2	JODAS EXPOIM PRIVATE LIMITED Accepted-Technical	Accepted-Technical Details in notice
3	Khandelwal Laboratories Pvt. Ltd. Accepted-Technical	Accepted-Technical Details in notice
4	Naprod Life Sciences Pvt Ltd Accepted-Technical	Accepted-Technical Details in notice

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

21 Aug 2026, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Dircetor

Address

Thycaud thiruvananthapuram

Work Description

Re-Tender for the procurement of anti cancer drugs for the year 2026-27

Tender Information

Tender ID

2026_KMSCL_865232_1

Reference Number

KMSCL/ED/ACD/RT/2026/019

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

365 days

Location

thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

22 documents required · 22 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredDocumentary proof that the firm is registered as per sl no 2 of Anx 1 (.pdf)

RequiredThe Details of offline EMD submitted as DD/BG as per sl no 3 of Anx 1 (.pdf)

RequiredThe Details of Re-inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 5 Anx 1 (.pdf)

RequiredBid offer form as sl no 6 Anx 1- pdf (.pdf)

RequiredBid offer form as sl no 7 Anx 1- xl (.xls)

RequiredNotary attested average annual turn over statement as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copies of original manufacturing license as per sl no 9 of Anx 1 (.pdf)

RequiredNotary attested copies of valid import license as per sl no 10 of Anx 1 (.pdf)

RequiredNotary attested copy of product wise market standing certificate as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license for the sale as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid WHO-GMP certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of non conviction certificate as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested performance stmt as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of power of attorney as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of under taking as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of under taking/declaration for replacement as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Balance sheets and P and L stmt as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested details of Technical personnel employed as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested details of the Bidder as per sl no 21 of Anx 1 (.pdf)

Finance

RequiredPrice bid form (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

16 Sept 2026

Published

11 Aug 2026

Bid Opening

24 Aug 2026

Download Starts

11 Aug 2026

Download Ends

21 Aug 2026

Submission Starts

11 Aug 2026

Clarification Period

11 Aug 2026 - 21 Aug 2026

Bill of Quantities

Item WiseBoQ_Ver3.0INR

BoQ1 (21 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount
1	AFATINIB TAB 30 mg	5,680	1 No	5	₹28,400
2	ANASTRAZOLE TAB IP 1mg	59,251	1 No	5	₹2,96,255
3	BICALUTAMIDE TAB IP 50mg	1,52,184	1 No	5	₹7,60,920
4	DAUNORUBICIN INJ IP 20 mg	642	Vial	5	₹3,210
5	DEXAMETHASONE TAB IP 8mg	1,27,416	1 No	5	₹6,37,080
6	DEXAMETHASONE TAB IP 4mg	1,43,651	1 No	5	₹7,18,255
7	MESNA INJ 200mg	4,254	Amp	5	₹21,270
8	POMALIDOMIDE CAP 2mg	8,345	1 No	5	₹41,725
9	SUNITINIB CAP 12.5mg	3,446	1 No	5	₹17,230
10	CARBOPLATIN INJ IP 150mg	10,017	Vial	5	₹50,085

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.02 MB

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.03 MB

Work Item Documents

FinalTenderdocumentACD.pdf

Tender Documents • 1.80 MB

BOQ_1464191.xls

BOQ • 0.31 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

Beta Drugs Limited

Accepted-Technical

NA | NA | NA | 121004

JODAS EXPOIM PRIVATE LIMITED

Accepted-Technical

Khandelwal Laboratories Pvt. Ltd.

Accepted-Technical

Naprod Life Sciences Pvt Ltd

Accepted-Technical

Sl No

Description

Qty

Unit

Est. Rate

Est. Amount

AFATINIB TAB 30 mg

5,680

1 No

₹28,400

ANASTRAZOLE TAB IP 1mg

59,251

1 No

₹2,96,255

BICALUTAMIDE TAB IP 50mg

1,52,184

1 No

₹7,60,920

DAUNORUBICIN INJ IP 20 mg

642

Vial

₹3,210

DEXAMETHASONE TAB IP 8mg

1,27,416

1 No

₹6,37,080

DEXAMETHASONE TAB IP 4mg

1,43,651

1 No

₹7,18,255

MESNA INJ 200mg

4,254

Amp

₹21,270

POMALIDOMIDE CAP 2mg

8,345

1 No

₹41,725

SUNITINIB CAP 12.5mg

3,446

1 No

₹17,230

CARBOPLATIN INJ IP 150mg

10,017

Vial

₹50,085